Literature DB >> 15380992

Atypical multifocal ERG responses in patients with diseases affecting the photoreceptors.

V C Greenstein1, K Holopigian, W Seiple, R E Carr, D C Hood.   

Abstract

The purpose of this study was to investigate atypical multifocal ERG (mfERG) responses for patients with diseases that can affect the photoreceptors. MfERGS were obtained from seven patients with retinitis pigmentosa (RP), three with progressive cone dystrophy (CD) and eight with diabetic retinopathy (DR). Both first- and second-order kernel responses were analyzed. The amplitudes and implicit times of the first-order responses were compared to those obtained from age-similar controls. For the first slice of the second-order response, the root-mean-square (RMS) and the signal-to-noise ratio (SNR) of each response were calculated. Achromatic visual fields were also obtained from each subject. For the three groups of patients, first-order responses with relatively large amplitudes, broad-shaped waveforms and markedly increased implicit times had non-measurable second-order responses. These responses were associated with areas of decreased visual field sensitivity. As RP, CD and DR affect the outer retina, the results are consistent with damage to the outer plexiform layer rather than damage to the inner retina.

Entities:  

Mesh:

Year:  2004        PMID: 15380992     DOI: 10.1016/j.visres.2004.06.020

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  13 in total

1.  Multifocal electroretinograms.

Authors:  Donnell J Creel
Journal:  J Vis Exp       Date:  2011-12-04       Impact factor: 1.355

Review 2.  A multifocal electroretinogram model predicting the development of diabetic retinopathy.

Authors:  Marcus A Bearse; Anthony J Adams; Ying Han; Marilyn E Schneck; Jason Ng; Kevin Bronson-Castain; Shirin Barez
Journal:  Prog Retin Eye Res       Date:  2006-09-01       Impact factor: 21.198

3.  Dynamics of retinal function after multiple photodynamic therapies in age-related macular degeneration: a report of cases.

Authors:  Beatrix Feigl; Brian Brown; Jan Lovie-Kitchin; Lawrence Lee
Journal:  Doc Ophthalmol       Date:  2006-03-06       Impact factor: 2.379

4.  Safety assessment in macaques of light exposures for functional two-photon ophthalmoscopy in humans.

Authors:  Christina Schwarz; Robin Sharma; William S Fischer; Mina Chung; Grazyna Palczewska; Krzysztof Palczewski; David R Williams; Jennifer J Hunter
Journal:  Biomed Opt Express       Date:  2016-11-16       Impact factor: 3.732

5.  The structure and function of the macula in patients with advanced retinitis pigmentosa.

Authors:  Rita Vámos; Erika Tátrai; János Németh; Graham E Holder; Delia Cabrera DeBuc; Gábor Márk Somfai
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-28       Impact factor: 4.799

6.  Preserved functional and structural integrity of the papillomacular area correlates with better visual acuity in retinitis pigmentosa.

Authors:  K Konieczka; R I Bojinova; C Valmaggia; D F Schorderet; M G Todorova
Journal:  Eye (Lond)       Date:  2016-08-05       Impact factor: 3.775

7.  Relationships among multifocal electroretinogram amplitude, visual field sensitivity, and SD-OCT receptor layer thicknesses in patients with retinitis pigmentosa.

Authors:  Yuquan Wen; Martin Klein; Donald C Hood; David G Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-21       Impact factor: 4.799

8.  Association between multifocal ERG implicit time delays and adaptation in patients with diabetes.

Authors:  Kevin W Bronson-Castain; Marcus A Bearse; Ying Han; Marilyn E Schneck; Shirin Barez; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-11       Impact factor: 4.799

9.  Multifocal electroretinogram in rhodopsin P347L transgenic pigs.

Authors:  Yiu-fai Ng; Henry H L Chan; Patrick H W Chu; Chi-ho To; Brian C Gilger; Robert M Petters; Fulton Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01-25       Impact factor: 4.799

10.  Multifocal ERG responses in infants.

Authors:  Ronald M Hansen; Anne Moskowitz; Anne B Fulton
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-21       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.